Example of Table Blog layout (FAQ section)

CHAPTER 10
Hits: 11289
Germanium - The Health & Life Enhancer

PREFACE    |   INTRODUCTION   |   CHAPTER 1   |   CHAPTER 2   |   CHAPTER 3   |   CHAPTER 4   |   CHAPTER 5   |   CHAPTER 6   |   CHAPTER 7   |   CHAPTER 8   |   CHAPTER 9   |   CHAPTER 10   |   CHAPTER 11   |   CHAPTER 12   |   CHAPTER 13   |   CHAPTER 14   |   CHAPTER 15   |   REFERENCES

{backbutton}

Therapeutic Effects On Other Conditions


Can Germanium "Cure" Every Illness?

The clinical literature contains case histories in which organic Germanium has been therapeutically successful in treating a wide range of illnesses and conditions. This literature spans reports from the Asai Germanium Clinic in Japan, clinical practitioners throughout Europe, and scientists and clinicians in the US.

Within the scientific and medical tradition, case histories are regarded as anecdotal evidence of a substance's efficacy, due to the lack of a controlled study, and therefore an inability to rigorously ascertain that the particular substance in question was responsible for the patient's improvement. Although rigorous, controlled studies are invaluable and perhaps indispensable in determining the therapeutic value of a substance, there is little sense in ignoring the information obtained from case studies, which can often provide the basis for more detailed research in an area.

Because of the relatively recent discovery of organic Germanium as a therapeutic agent, and the major research emphasis upon its cancer-healing attributes, information for many of its other therapeutic effects is still primarily contained in laboratory research and clinic case studies, which still constitute preliminary evidence. However, at this time, controlled clinical trials are ongoing in Japan for many types of illnesses, which hopefully can more fully document organic Germanium's effects on other conditions.

In view of organic Germanium's action at a fundamental body level which acts to restore homeostasis by a variety of health-enhancing effects - oxygenation, immune modulation, free radical scavenging - it is not surprising that this trace element can exert such a powerful effect in so many serious conditions. This chapter highlights Germanium's efficacy in treating a variety of conditions not already covered in this book.

Antifungal And Antimicrobial Activity

Organogermanium compounds, particularly trialkylgermanium acetates have demonstrated significant antifungal and antimicrobial activity in research studies (95). Bacteria which were inhibited by organic Germanium included Streptococcus lactis and Mycobacterium phlei.

At fairly low concentrations (100 ug/ml), organic Germanium inhibited growth of a variety of fungi, including Candida albicans, the proliferative yeast organism which can cause thrush. Yeast infections often follow courses of antibiotic treatment, due to the disruption of the body's microbial flora balance, and systemic yeast infections often occur in AIDS patients. The application of non-toxic organic Germanium as an antifungal agent would present a most promising therapeutic alternative to drugs such as nystatin, which are not always effective.
The basis of this antimicrobial and antifungal activity is most likely organic Germanium's oxygenation properties. Yeast organisms thrive in low oxygen (anaerobic) environments and are killed by oxygen. Organic Germanium augments metabolic oxygen levels which discourages the growth of pathogenic fungal organisms such as Candida.

Malaria

Malaria, a disease caused by various strains of the protozoan Plasmodium and transmitted by the Anopheles mosquito, has plagued huge areas of the world, including Africa, South America and the Asian continent. The symptoms of malaria involve sweats, fever and delirium, which correlate with the timing of each release of a new generation of parasites in the victim's bloodstream. The massive spraying of mosquito breeding grounds during the 1950's with DDT and other insecticides did temporarily appear to have "eradicated" malaria. However, the development of resistant strains of the parasite to these various chemicals has resulted in the re-emergence of malaria throughout the world. Developing a vaccine has proved to be a tricky problem, due to the parasite's successful strategy of evading the body's immune system. The traditional anti-malarial drug is chloroquine; however the parasite has developed resistance to this chemical.

A paper published in 1983 by Mrema et al in the International J. Clin. Pharmacol. Ther. and Tox (74) documented the antimalarial activity of Spirogermanium. The abstract from this paper is herein excerpted:

"Spirogermanium.....has revealed significant in vitro activity against chloroquine-resistant (FCB,FTA,FVO) and sensitive (FSL, FUI, FH) strains of Plasmodium falciparum. Inhibition of the growth and maturation of parasites after 36-h exposures to Spirogermanium started at concentrations ranging from 2.48 to 9.9 nM/ml. These concentrations appear to be within the range of Spirogermanium plasma levels reported in clinical studies with this drug. Since its clinical toxicities are unusually low in comparison with other anticancer drugs, our results on its in vitro activity against Plasmodium falciparum indicate Spirogermanium is an antimalarial drug of entirely novel structure, active in resistant strains."

The rights to Spirogermanium are owned by a New Jersey based company, Unimed, who are continuing research of Spirogermanium in several areas, including tropical medicine. There have been no other reports in the published literature about organic Germanium's therapeutic effects in malaria since the above-quoted study. In view of the devastating impact, worldwide, of malaria, developing a non-toxic and effective anti-malarial drug is an area certainly deserving thorough study and research.

Senile Osteoporosis

Senile osteoporosis, shrinking of the total bone mass, ischaracterized by bone fragility and increased incidence of fracture. Bone is composed essentially of collagen, calcium and phosphate and is in a dynamic state of constant resorption and formation. Bone mass is positively correlated with blood levels of the hormones estradiol testosterone and active cholecalciferol (previously called vitamin D3)and inversely related to levels of parathyroidhormone (PTH).

A 12 month study of patients with senile osteoporosis was conducted at Tokyo University, using a bone mineral analyzer to determine bone mineral content (71). Bone mass decreased in the control group of patients, while with those individuals given 1500 mg Ge-132 daily, bone mass increased with significant differences seen in 1 to 3 months from the start of taking Ge-132. The researchers considered that Ge-132 prevents bone mass decrease with aging. Usually, serum levels of PTH are high in senile osteoporosis patients; however, Ge-132 significantly reduced serum PTH levels. Therefore, the researchers postulate that organic Germanium's therapeutic effect in preventing bone mass decrease is exerted by decreasing serum levels of PTH.

This study demonstrates that organic Germanium exerts both a therapeutic and preventive effect upon senile osteoporosis, which can be of significant positive value for all aging people prone to this condition.

Heart Disease and Angina Pectoris

The following are summaries of case studies from Dr Asai's book:

  1. A 66 year old man suffered from sclerotic heart disease, with chest pains, bradycardia and slow pulse. Upon administration of Ge-132, the patient felt relief from the chest pains, and although still had difficulty walking, was able to climb a slope without frequent rests.
  2. In one case of angina pectoris, where coronary dilators were not effective, organic Germanium relieved the pain within a couple of days, and reduced the frequency of attacks from two or three times per day to almost nil. Attacks resumed upon stopping the administration of organic Germanium.
  3. One case of cardiac infarction involved a 45 year-old male, suffering an attack of sharp chest pain. A large dose of organic Germanium was administered; the pain subsided within a few minutes, and he fell asleep. ECG's taken over a period of three days showed "astonishing" improvement by the third day. The man recovered and was able to work normally.

Circulatory Problems - Raynaud's Disease

Raynaud's disease is a disease of the circulation, in which gangrene develops in the limbs, sometimes requiring amputation. Several successful cases treated with Ge-132 are reported from Dr. Asai's clinic, describing how following the administration of organic Germanium, gangrene was markedly reduced, and rosy colour restored, denoting good blood circulation (2).

Eye Diseases

Organic Germanium has been successfully used to treat eye diseases including glaucoma, black cataracts, detached retinas, inflammation of the retina and optic nerves. It is stated in Dr. Asai's book that "germanium rejuvenates retinal vessels, and is therefore effective in treating glaucoma and amaurosis". This area certainly is a fertile one for rigorous study.

Epilepsy

There are reports both of Ge-132 and Sanumgerman having success with epilepsy in children. In a report with a 16-year old boy taking Sanumgerman, there was an initial dramatic improvement in which for ten days there were no fits. Then after a fortnight a fit occurred, and gradually became as frequent as before the treatment. Increase in the dosage resulted in some improvement, but the initial success was never achieved (43).

Due to the difficulties involved with epilepsy, and the severely toxic effects of most of the available medication, this certainly points to yet another area to investigate more closely.

The Common Cold?

Organic germanium's anti-viral and immuno-enhancing properties enable speculation as to its possible preventative and therapeutic effects upon the common cold. This is certainly an area open to clinical research.

Other Diseases

Conditions which have responded to treatment with organic Germanium include chronic gastritis, influenza, Parkinson's disease, cerebral sclerosis, burns and multiple sclerosis.

footer
Copyright (c) Dr. S Goodman | 2010-2018. All right reserved.   Home      |      About Dr S Goodman      |    Editorials    |    Book Reviews    |    Books
footer
Dr GOodman on Facebook Blog for Dr Goodman Twitter Dr Goodman on LinkedIn